Targeting the ALX/FPR2 receptor in COPD

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1067547

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

An innovative research strategy will be applied to address chronic inflammation in a debilitating lung disease termed Chronic Obstructive Pulmonary Disease (COPD). This research will involve the therapeutic targeting of protective processes that normally switch off inflammation.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $391,327.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

chronic obstructive pulmonary disease (COPD) | inflammation | innate immunity | macrophage biology | respiratory diseases

Related Links